Showing results (271-280 of 305) with videos related to

Sort By:
Pageof 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de MoelleG Michel, G Socié, F Gebhard, et al.
British Journal of Haematology|February 14, 2002
Prior treatment with alpha interferon does not adversely affect the outcome of allogeneic transplantation for chronic myeloid leukaemiaA Pigneux, M L Tanguy, M Michallet, et al.
Leukemia & Lymphoma|December 30, 1998
A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemiaD Maraninchi, N Vey, P Viens, et al.
Leukemia & Lymphoma|April 1, 1997
Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'AdulteC Gisselbrecht, C Haioun, E Lepage, et al.
Leukemia|May 17, 2003
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantationM Mohty, K Bilger, E Jourdan, et al.
Blood|October 13, 2007
Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-alpha treatmentAndreas Hochhaus, Brian Druker, Charles Sawyers, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatmentJ Bienvenu, R Chvetzoff, G Salles, et al.
Bone Marrow Transplantation|January 1, 1996
Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemiaC Rozman, E Carreras, C Qian, et al.
Bone Marrow Transplantation|October 23, 1997
Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationF van Rhee, R M Szydlo, J Hermans, et al.
Blood|October 25, 2001
Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory diseaseV Leblond, V Lévy, F Maloisel, et al.
Pageof 31